Skip to content

On this page

Nulojix

belatacept

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Nulojix

Proper name

belatacept

Licence type

351(a)

BLA number

125288

Applicant

Bristol-Myers Squibb Company

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
250MG	For Injection	Intravenous	Single-Dose Vial	Rx	June 15, 2011

Exclusivity

Source: Purple Book

Kind	Expires
Orphan exclusivity	June 15, 2018

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity